In this episode, Dr. Dash, is joined by Dr. Rosa Coppolecchia, senior director of global clinical lead for thrombosis and vascular diseases at Bayer and assistant clinical professor of medicine at Hackensack Meridian School of Medicine. Dr. Coppolecchia shares her extensive 18-year experience in the pharmaceutical industry, focusing on cardiovascular and preventive medicine. They discuss her transition from practicing occupational medicine to joining Bayer in 2005, driven by personal experiences and a desire to impact cardiovascular health through research and clinical development. The conversation highlights her work on aspirin and other cardiovascular therapies, addressing health disparities, particularly among women, and the challenges and innovations in decentralized clinical trials. The discussion also touches on the evolution of cardiovascular disease treatment, the impact of new technologies like wearables and telemedicine, and the importance of patient education and compliance. Dr. Coppolecchia also shares her involvement in promoting STEM education among young women through the American Heart Association.